NovoCare Pharmacy

NovoCare Pharmacy is Novo Nordisk’s direct-to-patient channel, selling Wegovy and Ozempic for cash without insurance. This page explains the structure and the open questions.

Pricing data as of 2026-07-30.

Flat pricing, with one unresolved question

The direct cash price for the injectable products has been reported as flat across doses, which if true makes NovoCare unusually simple to reason about compared with tiered programs.

The oral product is where the reporting conflicts. Two different monthly figures are in circulation for the starting dose. They may describe genuinely different things, such as a first-fill price against an ongoing price, or a direct price against a retail price with a savings offer applied. We could not establish which, and we will not average two figures into a third that no one charges. Until it is resolved, that price renders as unverified.

Cash-pay and your deductible

As with any manufacturer direct-pay program, paying cash bypasses your insurance, so the amount does not count toward your deductible or out-of-pocket maximum. A prescription is still required.

Every figure we hold for this pathway

Compare it against everything else

A single pathway in isolation cannot tell you whether it is your cheapest option. Use the tool to rank this pathway against every other one for your medication, your insurance situation and your dose.